Fagron NV operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Fagron NV with three other
pharmaceutical manufacturers in Europe:
Amarin Corporation PLC
of UNITED KINGDOM
(2020
sales of £475.12 million [US$652.63 million]
of which 100%
was Single segment),
Dechra Pharmaceuticals PLC
of UNITED KINGDOM
(£515.10 million [US$707.56 million]
of which 63%
was European Pharmaceuticals), and
Indivior Plc
which is
also
based in UNITED KINGDOM
(£500.60 million [US$687.64 million]
of which 78%
was Sublingual/Other).
Sales Analysis.
During the year ended December of 2020, sales at
Fagron NV were 555.97 million Euro (US$660.30 million).
This
is
an
increase of 4.0%
versus 2019, when the company's sales were 534.70 million Euro.
This was the fourth straight year of sales growth at Fagron NV.